Cargando…
In vitro Activity of Repurposed Nitroxoline Against Clinically Isolated Mycobacteria Including Multidrug-Resistant Mycobacterium tuberculosis
Antimicrobial treatment options for mycobacterial infections are limited due to intrinsic resistance and the emergence of acquired resistance in Mycobacterium tuberculosis. Isolates resisting first- and second line drugs are raising concerns about untreatable infections and make the development of n...
Autores principales: | Hoffmann, Ada Marie, Wolke, Martina, Rybniker, Jan, Plum, Georg, Fuchs, Frieder |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198898/ https://www.ncbi.nlm.nih.gov/pubmed/35721137 http://dx.doi.org/10.3389/fphar.2022.906097 |
Ejemplares similares
-
Repurposing of Nitroxoline as an Alternative Primary Amoebic Meningoencephalitis Treatment
por: Chao-Pellicer, Javier, et al.
Publicado: (2023) -
In vitro activity of mecillinam, temocillin and nitroxoline against MDR Enterobacterales
por: Plambeck, Lars, et al.
Publicado: (2022) -
Susceptibility of Aerococcus urinae and Aerococcus sanguinicola to Standard Antibiotics and to Nitroxoline
por: Ahmadzada, Aysel, et al.
Publicado: (2023) -
Preclinical pharmacodynamic evaluation of antibiotic nitroxoline for anticancer drug repurposing
por: ZHANG, QI, et al.
Publicado: (2016) -
Repurposing Cefazolin-Avibactam for the Treatment of Drug Resistant Mycobacterium tuberculosis
por: Srivastava, Shashikant, et al.
Publicado: (2021)